Симбикорт Турбухалер

Симбикорт Турбухалер is an inhaled corticosteroid and long-acting beta2-agonist combination used for maintenance treatment of asthma and COPD. This combination therapy helps reduce inflammation and open airways. Find reliable inhalation solutions for respiratory support.

Симбикорт Турбухалер is used as a maintenance treatment to control and prevent symptoms of asthma and chronic obstructive pulmonary disease (COPD). It combines budesonide, an anti-inflammatory corticosteroid, with formoterol fumarate dihydrate, a bronchodilator that helps relax airway muscles. This dual-action therapy is designed for regular use to reduce flare-ups and improve breathing.

Users often report improved breathing comfort and reduced frequency of wheezing or shortness of breath during daily activities. The medication works gradually over time to help maintain open airways and reduce lung inflammation. Some may notice better sleep quality due to fewer nighttime symptoms.

Keep the inhaler dry and store at room temperature away from direct heat or cold. Always check the dose counter before use and discard after the indicated number of doses. Rinse your mouth with water after inhalation to reduce the risk of oral thrush. Follow the prescribed schedule even if symptoms improve.

Avoid using other inhaled corticosteroids or long-acting beta agonists unless directed by a healthcare provider. Certain medications, such as strong CYP3A4 inhibitors (e.g., ketoconazole), may increase the risk of side effects. Discuss all current medications with your doctor to ensure safe use.